NULEXA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

NULEXA Trademark

Serial Number: 99483119

NULEXA is a trademark filed by Ortho-Clinical Diagnostics, Inc. on November 6, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Ortho-Clinical Diagnostics, Inc.

1001 U.S. Highway Route 202 S
Raritan, NJ 08869

Entity Type: 03

Trademark Details

Filing Date

November 6, 2025

Registration Date

Not Registered

Published for Opposition

May 12, 2026

Goods & Services

Medical diagnostic apparatus for testing and analyzing blood and other bodily fluids; Medical diagnostic apparatus for testing for viruses; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Sample preparation device for medical diagnostic uses; Medical diagnostic apparatus for testing blood and other bodily fluids incorporating recorded operating system software; Medical diagnostic apparatus for detecting viruses and bacteria with embedded operating Software in a Medical Device (SiMD); Medical diagnostic apparatus for detecting viruses and bacteria

Medical services, namely, medical molecular diagnostic, testing, monitoring, and reporting services

Medical diagnostic test media in the form of a cartridge for measuring, testing and analyzing blood and other bodily fluids for use in the detection of infectious diseases, including viral and bacterial pathogens; Diagnostic reagents for medical use in in vitro diagnosis; In vitro diagnostic preparations for medical use; In vitro diagnostic preparations for medical purposes; Medical diagnostic reagents and assays for testing of body fluids; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, viral and bacterial pathogens; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Influenza A, Influenza B, SARS-CoV-2, Respiratory Syncytial Virus (RSV), and Group A Streptococcus (Strep A); Diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes; Diagnostic kits comprising diagnostic agents, preparations and substances for medical use; Diagnostic test reagents for medical use; Diagnostic test reagents for medical purposes; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of body fluids; Diagnostic chemical reagents for medical use; Diagnostic chemical reagents for medical purposes

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 15, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 7, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 2, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 2, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 2, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 18, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Nov 6, 2025 MAFR
NEW APPLICATION ENTERED
Nov 6, 2025 NWAP